Preterm Birth And PROM Testing Market Size, Share, Trends, Growth Outlook

Preterm Birth And PROM Testing Market is estimated to increase at a growth rate of 8.1% CAGR over the forecast period from 2024 to 2030.

The global Preterm Birth And PROM Testing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin, Others), By Application (PROM, Preterm Labor, Chorioamnionitis).

An introduction to Preterm Birth And PROM Testing Market in 2024

In 2024, the preterm birth and preterm premature rupture of membranes (PROM) testing market are witnessing significant growth, driven by the global burden of preterm birth complications, advancements in diagnostic testing technologies, and the increasing emphasis on early detection and intervention to reduce neonatal morbidity and mortality. Preterm birth and PROM testing encompass a range of diagnostic assays and biomarker panels for predicting, diagnosing, and managing preterm labor, premature rupture of membranes, and related pregnancy complications. With innovations in biochemical markers, ultrasound imaging, and point-of-care testing platforms, the market is experiencing rapid expansion and adoption of preterm birth and PROM testing solutions, enabling healthcare providers to identify high-risk pregnancies, optimize prenatal care, and improve perinatal outcomes for mothers and infants.

Preterm Birth And PROM Testing Market Trend: Increasing Focus on Early Detection and Management

A significant trend in the Preterm Birth and PROM Testing Market is the growing emphasis on early detection and management strategies to reduce the incidence of preterm birth and prevent complications associated with preterm premature rupture of membranes (PROM). Healthcare providers and policymakers are increasingly recognizing the importance of implementing screening programs and diagnostic tests to identify women at risk of preterm birth and PROM. Advances in prenatal screening technologies, including biomarker assays and ultrasound imaging, are enabling more accurate and timely identification of high-risk pregnancies, facilitating proactive interventions and personalized care plans to optimize maternal and fetal outcomes.

Preterm Birth And PROM Testing Market Driver: Rising Prevalence of Preterm Births and Maternal Health Concerns

The primary driver of the Preterm Birth and PROM Testing Market is the escalating prevalence of preterm births and maternal health concerns globally. Preterm birth is a leading cause of neonatal morbidity and mortality, with significant healthcare costs and long-term health implications for affected infants. Factors such as maternal age, multiple pregnancies, lifestyle habits, and medical conditions contribute to the increased risk of preterm labor and PROM. As healthcare systems strive to address the rising burden of preterm birth-related complications, there is growing demand for innovative diagnostic tests and screening tools to identify women at risk and implement timely interventions to prolong gestation and improve neonatal outcomes.

Preterm Birth And PROM Testing Market Opportunity: Development of Non-Invasive and Point-of-Care Testing Solutions

An opportunity within the Preterm Birth and PROM Testing Market lies in the development of non-invasive and point-of-care testing solutions that offer rapid and accurate assessment of preterm birth risk and PROM status. Current diagnostic methods often involve invasive procedures, such as amniocentesis or cervical length measurement, which may carry risks and require specialized expertise and infrastructure. By investing in research and development efforts, manufacturers can explore novel biomarkers, imaging techniques, and point-of-care devices that enable non-invasive and user-friendly screening for preterm birth and PROM. Such innovations could revolutionize prenatal care delivery, empowering healthcare providers with actionable information to guide clinical decision-making and improve pregnancy outcomes, particularly in resource-limited settings where access to specialized diagnostic facilities may be limited.

Preterm Birth And PROM Testing Market Market Segmentation

By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Preterm Birth And PROM Testing Market Companies

Abbott
Biosynex
Clinical Innovations Llc
Cooper Surgical Inc
Hologic Inc
IQ Products
Medixbiochemica
NX Prenatal Inc
Qiagen N.V.
Sera Prognostics

Reasons to Buy the Preterm Birth And PROM Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Preterm Birth And PROM Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Preterm Birth And PROM Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Preterm Birth And PROM Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Preterm Birth And PROM Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Preterm Birth And PROM Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Preterm Birth And PROM Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Preterm Birth And PROM Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Preterm Birth And PROM Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Preterm Birth And PROM Testing Industry
4.2 Key Market Trends in Preterm Birth And PROM Testing Industry
4.3 Potential Opportunities in Preterm Birth And PROM Testing Industry
4.4 Key Challenges in Preterm Birth And PROM Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Preterm Birth And PROM Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Preterm Birth And PROM Testing Market Outlook by Segments
7.1 Preterm Birth And PROM Testing Market Outlook by Segments, $ Million, 2021- 2030
By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis

8 North America Preterm Birth And PROM Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Preterm Birth And PROM Testing Markets in 2024
8.2 North America Preterm Birth And PROM Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Preterm Birth And PROM Testing Market size Outlook by Segments, 2021-2030
By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis

9 Europe Preterm Birth And PROM Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Preterm Birth And PROM Testing Markets in 2024
9.2 Europe Preterm Birth And PROM Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Preterm Birth And PROM Testing Market Size Outlook by Segments, 2021-2030
By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis

10 Asia Pacific Preterm Birth And PROM Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Preterm Birth And PROM Testing Markets in 2024
10.2 Asia Pacific Preterm Birth And PROM Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Preterm Birth And PROM Testing Market size Outlook by Segments, 2021-2030
By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis

11 South America Preterm Birth And PROM Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Preterm Birth And PROM Testing Markets in 2024
11.2 South America Preterm Birth And PROM Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Preterm Birth And PROM Testing Market size Outlook by Segments, 2021-2030
By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis

12 Middle East and Africa Preterm Birth And PROM Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Preterm Birth And PROM Testing Markets in 2024
12.2 Middle East and Africa Preterm Birth And PROM Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Preterm Birth And PROM Testing Market size Outlook by Segments, 2021-2030
By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Biosynex
Clinical Innovations Llc
Cooper Surgical Inc
Hologic Inc
IQ Products
Medixbiochemica
NX Prenatal Inc
Qiagen N.V.
Sera Prognostics
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Pelvic exam
Ultrasound
Biochemical Markers
-Interleukin 6
-C-Reactive Protein
-IL-1, IL-2, IL-8, TNF-a
-Corticotropin-Releasing Hormone
-Alpha-fetoprotein
Uterine Monitoring
Nitazine Test
Ferning Test
Pooling
PAMG-1 Immunoassay
IGFBP Test
Fetal Fibronectin
Others
By Application
PROM
Preterm Labor
Chorioamnionitis